As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone
March 9, 2022 As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation.
March 9, 2022 As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder aloneAlmost
/PRNewswire/ Abbott (NYSE: ABT) today announced the world s first patient implants of a dual-chamber leadless pacemaker system as part of its AVEIR DR i2i™.